LifeSciences BC is governed by a Board of Directors, whose members represent British Columbia’s biopharmaceutical, biotechnology, medical devices, digital health and greater life sciences community. Our board provides guidance, sets policy and ensures that the organization operates effectively in achieving its mandate, which is to foster the economic development of B.C.’s life sciences industry.
Scott Phillips – Founder & CEO, Starfish Medical Inc.
Ali Ardakani – Founder & Managing Director, Novateur Ventures Inc.
Ian Heine – Partner, PwC
Jennifer Cudlipp – President, Excelleris Technologies Inc.
Dr. Pieter Cullis – Professor, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia
James Hatton, QC – Partner, Farris, Vaughan, Wills & Murphy LLP
Rajveer Hundal – Partner, PwC Canada
Dr. David Llewellyn – Senior Vice President, Business Operations, STEMCELL Technologies
Michael R. Martin – COO and Head, Global Business Development, Aurinia Pharmaceuticals Inc.
Peter Simpson – Former, Senior Manager of Government Affairs with GlaxoSmithKline
Anne Stevens – COO and Director, Aequus Pharmaceuticals
Dr. Pascal Spothelfer – President and CEO, Genome BC
Dr. Gavin Stuart – Vice Provost Health, Faculty of Medicine, University of British Columbia
Dr. James Taylor – CEO, Precision Nanosystems Inc.
Observers to the Board
Joseph Garcia – Partner, Blake, Cassels & Graydon LLP
Hector MacKay-Dunn, J.D. Q.C. – Senior Partner, Farris, Vaughan, Wills & Murphy LLP
Roger Kuypers – Partner, Fasken, Martineau, DuMoulin LLP